Home
Aristo Bio-tech & Lifescience Ltd PE Ratio

Aristo Bio-Tech & Lifescience Ltd
NSE: ARISTOBIOTECH
PE
Key Highlights
- The P/E Ratio of Aristo Bio-Tech & Lifescience Ltd is 18.4 as of 21 Feb 25 .
- The P/E Ratio of Aristo Bio-Tech & Lifescience Ltd changed from 10.7 on March 2023 to 10.9 on March 2024 . This represents a CAGR of 0.93% over 2 years.
- The Latest Trading Price of Aristo Bio-Tech & Lifescience Ltd is ₹ 105 as of 21 Feb 15:30 .
- The PE Ratio of Agro Chemicals Industry has changed from 15.6 to 90.0 in 5 years. This represents a CAGR of 41.98%.
- The PE Ratio of Agro Chemicals industry is 90.0. The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Aristo Bio-Tech & Lifescience Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Aristo Bio-Tech & Lifescience Ltd
Company Fundamentals for Aristo Bio-Tech & Lifescience Ltd

Aristo Bio-Tech & Lifescience Ltd
NSE: ARISTOBIOTECH
Share Price
Market Price of Aristo Bio-Tech & Lifescience Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 105 |
19 Feb 2025 | 105 |
17 Feb 2025 | 105 |
12 Feb 2025 | 116.8 |
11 Feb 2025 | 110.55 |
07 Feb 2025 | 126.5 |
06 Feb 2025 | 120.5 |
04 Feb 2025 | 125 |
03 Feb 2025 | 122.55 |
31 Jan 2025 | 129 |
SWOT Analysis Of Aristo Bio-Tech & Lifescience Ltd
BlinkX Score for Aristo Bio-Tech & Lifescience Ltd
Asset Value vs Market Value of Aristo Bio-Tech & Lifescience Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
PE Ratio of Aristo Bio-Tech & Lifescience Ltd Explained
₹71.48
Market cap
₹3
Earnings
18.4X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Agro Chemicals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Aristo Bio-Tech & Lifescience Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Aristo Bio-Tech & Lifescience Ltd
Historical Revenue, EBITDA and Net Profit of Aristo Bio-Tech & Lifescience Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Aristo Bio-Tech & Lifescience Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Aristo Bio-Tech & Lifescience Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Aristo Bio-Tech & Lifescience Ltd
About Aristo Bio-Tech & Lifescience Ltd
- Aristo Bio-Tech & Lifescience Limited was originally incorporated on March 17, 2005 as 'Aristo Bio-Tech and Lifescience Private Limited' with the Registrar of Companies, Maharashtra, Mumbai.
- Subsequently Company converted into Public Limited Company and name of company was changed to 'Aristo Bio-Tech and Lifescience Limited' vide fresh Certificate of Incorporation dated May 20, 2020. Aristo Bio-Tech & Lifescience is an agrochemical company engaged in the manufacturing, formulation, supplying, packaging and job work services in various Pesticides such as Insecticides, Herbicides, Fungicides, Plant Growth Regulators and other Agrochemicals.
- Agrochemical industries deals with production and distribution of pesticides and fertilizers to increase the crop yields.
- Agrochemicals pesticides are designed to protect crops from insects, diseases and weeds.
Aristo Bio-Tech & Lifescience Ltd News Hub
Aristo Bio-Tech & Life science AGM scheduled
Aristo Bio-Tech & Life science announced that the 19th Annual General Meeting (AGM) of the company w
Read more
29 Aug 24
Aristo Bio-Tech & Life science schedules board meeting
Aristo Bio-Tech & Life science will hold a meeting of the Board of Directors of the Company on 13 No
Read more
09 Nov 24
Aristo Bio-Tech & Life science to convene board meeting
Aristo Bio-Tech & Life science will hold a meeting of the Board of Directors of the Company on 14 No
Read more
14 Nov 24